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The Staphylococcus intermedius group (SIG) includes zoonotic pathogens traditionally associated with dog bites. We describe a
simple scheme for improved detection of SIG using routine laboratory methods, report its effect on isolation rates, and use se-
quencing to confirm that, apart from one atypical SIG strain, most isolates are Staphylococcus pseudintermedius.
Staphylococcus intermedius sensu lato is a veterinary pathogenoccasionally reported from infected-animal (particularly dog)
bites in humans (1, 2). Originally thought to be a single species,
molecular characterization has resulted in its reclassification as
Staphylococcus intermedius group (SIG), which includes S. inter-
medius, S. pseudintermedius, and S. delphini (3, 4). Non-bite-asso-
ciated human isolates were reported in 1994 (5), but little has been
documented since. Our aim was to improve the detection and
identification of SIG from human samples using a simple pheno-
typic algorithm. This initial identification was confirmed by se-
quencing fragments of two housekeeping genes which were also
used to determine diversity within SIG isolates.
Initially, one of us (J. Lee) undertook a training session for
laboratory staff to raise awareness of SIG and their colonial mor-
phology and explain the algorithm. This was supplemented by
posters in the laboratory and regular feedback. Following this,
wound swabs (principally from skin and soft-tissue infections)
were screened for SIG over the period from October 2010 to Sep-
tember 2013 at the Department of Clinical Microbiology, Royal
Cornwall Hospital, Cornwall, United Kingdom. The specimens
had been submitted for routine investigation from local hospitals
and primary care physicians. Clinical details were taken from lab-
oratory request forms accompanying the specimens from which
SIG bacteria were isolated. No extra information was sought from
requesting clinicians.
Swabs were inoculated onto horse blood agar (Oxoid) and ex-
amined after overnight incubation in 5% CO2, our standard lab-
oratory procedure. Bacterial colonies typical of SIG—white, en-
tire, convex, glistening colonies 5 to 6mm in diameter (see Fig. S1
in the supplemental material)—were selected for further charac-
terization using a simple algorithm (Fig. 1). Briefly, suspect colo-
nies were tested with a commercial latex reagent for clumping
factor/protein A detection (Prolab StaphXtra) and forDNase pro-
duction using commercial medium (Oxoid). Isolates that were
latex negative and produced DNase were processed by the
VITEK2 (bioMérieux) automated identification/susceptibility
system using GP/AST cards. Strains identified by VITEK2 as
“Staphylococcus intermedius” underwent PCR amplification of
fragments of the housekeeping genes hsp60 and sodA using pub-
lished primer pairs (6, 7). Sequences were trimmed, aligned, and
analyzed with MEGA5 (8). Sensitivity testing was performed by
using the VITEK2 system and the AST-P578 panel, interpreted by
EUCAST guidelines. Sensitivity results were compared with those
of 40 consecutive community-acquired Staphylococcus aureus iso-
lates from our laboratory.
No SIG isolates were recovered in our laboratory in the year
preceding the study. SIG bacteria were isolated on 40 occasions
from 39 patients during the study period. Sites of isolation in-
cluded wounds (57%), ears (19%), diabetic ulcers (12%), dog
bites (7%), and cutaneous ulcers (5%). Clinical details included
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FIG 1 Phenotypic algorithm for the detection of SIG isolates.
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impetigo, cellulitis, erythema, pain, purulent exudate, inflamma-
tion, and postsurgical infection. A history of animal contact was
given in 4 of 40 requests; 2 of these were identified as bite wounds.
The algorithm was fully operational between May 2012 and Sep-
tember 2013. During this 16-month period, SIG and S. aureus
were isolated 32 and 10,777 times, respectively, from 39,380 spec-
imens.
Sequencing confirmed that all but one SIG isolate identified by
the algorithm belonged to S. pseudintermedius. Analysis of sodA
and hsp60 sequences revealed that the S. pseudintermedius strains,
all isolated from local residents, were closely related (Fig. 2). One
divergent strain, NW1, which came from a visitor to Cornwall,
United Kingdom, could not be assigned to a recognized SIG spe-
cies (Fig. 2). The sodA sequence of this strain was identical to a
“staphylococcal species” described previously by Slettemeås and
colleagues (9). The hsp60 sequence from this strain had 95% se-
quence similarity to an S. intermedius strain isolated fromapigeon
(10) (see Fig. S2 in the supplemental material).
The antibiotic susceptibilities of SIG isolates resembled those
of local community-acquired S. aureus bacteria with universal
susceptibility to oxacillin, erythromycin, fusidic acid, chloram-
phenicol, ciprofloxacin, clindamycin, gentamicin, linezolid, and
rifampin. Tetracycline resistance was more common (15% versus
4.7%) in SIG isolates than in S. aureus. Polymyxin MICs were
higher (range, 8 to 24 mg/liter) for S. pseudintermedius strains
than for strain NW1 (4 mg/liter).
Our results show that it is possible to identify SIG isolates using
standard laboratory procedures. Recognition of the colonial mor-
phology of SIG is essential for successful detection. Where this is
followed by a simple algorithm, SIG can be identified reliably in
clinical specimens. Before this method was introduced in our lab-
oratory, SIG isolates were undetected and almost certainly under-
reported. Our study was limited in scope and did not attempt to
identify colonies that were morphologically atypical, did not seek
SIG among “latex-positive” strains, and did not perform genotyp-
ing on staphylococcal isolates which VITEK2 identified as non-
SIG strains. It is therefore likely that some SIG strains weremissed
and that the true prevalence of these organisms is higher than our
results suggest.
In our population, S. pseudintermedius is readily detected, un-
like S. intermedius sensu stricto. This confirms recent findings that
“S. intermedius infections” described in earlier reports were likely
to be S. pseudintermedius infections (11). We also isolated a SIG
isolate belonging to a distinct, uncharacterized lineage that has
been reported only once before (9). This isolate, NW1, had re-
duced susceptibility to polymyxin, which is a feature of S. inter-
medius sensu stricto and S. delphini (4). It may be a new species in
the SIG group (9).
The clinical details given by requesting clinicians were of little
use in predicting SIG isolation; very few noted animal contact.
This probably reflects the limited information supplied by clini-
cians rather than an absence of zoonotic risk. The pattern of sam-
ples yielding SIG resembled that for S. aureus, which supports a
pathogenic role for S. pseudintermedius in humans. A number of
SIG isolates came from diabetic patients, an association which
warrants further study. Susceptibility to antistaphylococcal anti-
biotics was similar to that of community-acquired S. aureus iso-
lates but with decreased susceptibility to tetracycline; this may
reflect veterinary prescribing practice (12).
In conclusion, SIG bacteria are underreported and often found
where there is no stated history of animal contact to guide inves-
tigations. A simple modification of routine laboratory methods
results in better detection of these organisms. Reporting of clinical
isolates as “Staphylococcus intermedius group” when identified by
phenotype is accurate and should be adopted by clinical laborato-
ries.
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